Even as Johnson & Johnson is settling previous charges that may cost about $2.2 billion, the government is making new inquiries into allegations that the company used illegal tactics to promote and market its drugs, the Wall Street Journal reports.
According to the Wall Street Journal, the U.S. Justice Department sent J&J’s Janssen Pharmaceuticals unit a letter in April, requesting documents related to the marketing and promotion of the antibiotic Doribax.
In ...
continue reading...